These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16827981)

  • 41. Comparison of the antiplatelet effect of clopidogrel hydrogenosulfate and clopidogrel besylate in patients with stable coronary artery disease.
    Hamilos M; Saloustros I; Skalidis E; Igoumenidis N; Kambouris M; Chlouverakis G; Vougia D; Loggakis I; Vardas PE; Kochiadakis G
    J Thromb Thrombolysis; 2015 Oct; 40(3):288-93. PubMed ID: 25662861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spontaneous chest wall hematoma with dual antiplatelet therapy.
    Bevan P; Menon A; Bunton R
    Can J Cardiol; 2014 Feb; 30(2):247.e1-2. PubMed ID: 24290862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety of ultrasound-guided small-bore chest tube insertion in patients on clopidogrel.
    Dammert P; Pratter M; Boujaoude Z
    J Bronchology Interv Pulmonol; 2013 Jan; 20(1):16-20. PubMed ID: 23328136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-PCI fatal bleeding in aspirin and clopidogrel hyper responder: shifting from antiplatelet resistance to bleeding risk assessment?
    Cuisset T; Frere C; Quilici J; Uhry S; Alessi MC; Bonnet JL
    Int J Cardiol; 2010 Jan; 138(2):212-3. PubMed ID: 18707772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
    Luinstra M; Naunton M; Peterson GM; Bereznicki L
    J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
    JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delayed traumatic hemothorax on ticlopidine and aspirin for coronary stent.
    Quinn MW; Dillard TA
    Chest; 1999 Jul; 116(1):257-60. PubMed ID: 10424539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention.
    Breet NJ; van Werkum JW; Bouman HJ; Kelder JC; Harmsze AM; Hackeng CM; ten Berg JM
    Heart; 2011 Jun; 97(12):983-90. PubMed ID: 21478385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery.
    Plicner D; Mazur P; Hymczak H; Stoliński J; Litwinowicz R; Drwiła R; Undas A
    Thromb Res; 2015 Sep; 136(3):519-25. PubMed ID: 26003782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemorrhage associated with combined clopidogrel and aspirin therapy.
    Chapman TW; Bowley DM; Lambert AW; Walker AJ; Ashley SA; Wilkins DC
    Eur J Vasc Endovasc Surg; 2001 Nov; 22(5):478-9. PubMed ID: 11735194
    [No Abstract]   [Full Text] [Related]  

  • 51. Clopidogrel: a pharmacoeconomic review of its use in patients with non-ST elevation acute coronary syndromes.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2006; 24(7):709-26. PubMed ID: 16802846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparative assessment of antiaggregant efficacy of acetylsalicylic acid and clopidogrel in peripheral atherosclerosis].
    Kuznetsov MR; Sergeeva NA; Koshkin VM; Boldin BV; Rodionov SV; Virganskiĭ AO; Kosykh IV; Lisenkov OP; Kuznetsova VF
    Angiol Sosud Khir; 2014; 20(1):8-14. PubMed ID: 24722015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bleeding complication with dual antiplatelet therapy: spontaneous uvula hematoma.
    Kounis NG; Davlouros P
    CMAJ; 2014 Oct; 186(15):1168. PubMed ID: 25200759
    [No Abstract]   [Full Text] [Related]  

  • 54. Successful liver transplantation with continued dual antiplatelet therapy.
    Spieker H; Benckert C; Quante M; Thelen A; Gaebelein G; Kaisers U; Jonas S
    Ann Transplant; 2012; 17(2):127-30. PubMed ID: 22743731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease.
    Strobl FF; Brechtel K; Schmehl J; Zeller T; Reiser MF; Claussen CD; Tepe G
    J Endovasc Ther; 2013 Oct; 20(5):699-706. PubMed ID: 24093324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation.
    Czerwińska-Jelonkiewicz K; Witkowski A; Dąbrowski M; Piotrowski W; Hryniewiecki T; Stępińska J
    Arch Cardiovasc Dis; 2018 Apr; 111(4):233-245. PubMed ID: 29126843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects.
    Traby L; Kollars M; Kaider A; Eichinger S; Wolzt M; Kyrle PA
    J Thromb Haemost; 2016 Feb; 14(2):273-81. PubMed ID: 26663880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS).
    Bertrand ME; Rupprecht HJ; Urban P; Gershlick AH;
    Circulation; 2000 Aug; 102(6):624-9. PubMed ID: 10931801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
    Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
    Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.